Inclisiran: a new milestone on the PCSK9 road to tackle cardiovascular risk

Gaetano Santulli^{1

2

3}, Stanislovas S Jankauskas^{1

2}, Jessica Gambardella^{1

2

3}

Affiliations

¹ Department of Medicine, Wilf Family Cardiovascular Research Institute, Einstein Institute for Aging Research, Albert Einstein College of Medicine, New York, NY 10461, USA.
² Department of Molecular Pharmacology, Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Fleischer Institute for Diabetes and Metabolism (FIDAM), Albert Einstein College of Medicine, New York, NY 10461, USA.
³ Department of Advanced Biomedical Science, 'Federico II' University, and International Translational Research and Medical Education Consortium (ITME), 80131 Naples, Italy.

Gaetano Santulli et al. Eur Heart J Cardiovasc Pharmacother. 2021.

. 2021 May 23;7(3):e11-e12.

doi: 10.1093/ehjcvp/pvab014.

Gaetano Santulli^{1

2

3}, Stanislovas S Jankauskas^{1

2}, Jessica Gambardella^{1

2

3}

¹ Department of Medicine, Wilf Family Cardiovascular Research Institute, Einstein Institute for Aging Research, Albert Einstein College of Medicine, New York, NY 10461, USA.
² Department of Molecular Pharmacology, Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Fleischer Institute for Diabetes and Metabolism (FIDAM), Albert Einstein College of Medicine, New York, NY 10461, USA.
³ Department of Advanced Biomedical Science, 'Federico II' University, and International Translational Research and Medical Education Consortium (ITME), 80131 Naples, Italy.

No abstract available

MeSH terms